Upon first read-through, I thought I understood what this paper was reporting: That early microglial activation occurred in response to a stressor, but over time (chronic stress) microglia number decreased and morphology became dystrophic. This is what is suspected to cause depressive-like symptoms. However when I went back through the paper to understand the details better, I found a few confusing points that I couldn’t seem to wrap my head around. It says minocycline and imipramine had anti-depressive effects, along with IL-1 receptor antagonists, but in the next sentence it says the two did not have any anti-depressive effects. Later, the paper also states that minocycline only had anti-depressive effects in US mice, not CUS mice. I think my confusion stems from not fully understanding the role that minocycline or imipramine plays in both immune activation and then later depressive symptoms. Are they supposed to be showing less immune activation and thus reduction in depressive symptoms? Or do they show that they are not affecting depressive symptoms, but do impact the immune response in some way? My best guess/interpretation is that these compounds are decreasing the initial immune response in response to stress, and for this reason do not cause a subsequent immune depression in response to chronic stress. This then results in decreased depressive-like symptoms. If this is the correct interpretation of the data, then I think my confusion continues to stem from not understanding the mechanism behind these changes or why these effects are seen.
Additionally, I also am having a hard time understanding the role of the IL-1raTG mice in this experiment. Does it show that IL-1 is a cytokine that will activate an immune response in response to stress, so when a mouse no longer has that receptor, the immune activation is no longer seen? Overall, the role that the IL-1, receptors, and IL-1 converting enzyme play in depressive like symptoms is a little confusing. I think discussing those figures in particular in class would help me to better understand the role each one plays in immune activation, and what is considered desirable for ameliorating depressive symptoms.
Overall, I really enjoyed this paper, and am very interested in any future findings that come from research on how stress and immunity play off of one another. Although, I think this paper could have benefited from choosing to present their data a little differently. I keep getting lost in the overwhelming amount of panels in each figure, and tend to confuse the different experimental treatments with what the desired results should be, as in the case of minocycline or the IL-1raTG mice for example.
YES--those figures were insane. Once you have to label all the way through 'o' something is wrong!
ReplyDelete